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BIOMONITORING OF LIPIDS, ENZYMES, AND CREATINE KINASE
IN PATIENTS WITH STATINS THERAPY
The aim of the study is to conduct biomonitoring of 
the cytotoxic effect of statins in patients with 
dyslipidemia
Material and methods: The subjects are patients with confirmed 
dyslipidemia, with increased concentration of cholesterol in the 
blood and on therapy with statins, in order to reduce the risk of 
cardiovascular diseases. The patients were divided into groups 
according to their age and type of the statins therapy.
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Група А
(Atorvastat
in)
AST
(10-
34) 
U/L
ALT
(10-45) 
U/L
Група Б
(Rosuvas
tatin)
AST
(10-
34) 
U/L
ALT
(10-
45) 
U/L
1 87 57 1 46 60
2 57 112 2 264 343
3 56 63 3 87 68
4 56 71 4 81 77
5 47 52 5 110 112
6 206 306
7 207 297
mean 60.6 71 143 180.4
2
St.Dev 7.65 21.45 75.76 118.5
Параметри [mean ± SD] Min Max
Chol(mmol/L) [6.55 ± 2.035] 3.5 10.17
TG (mmol/L) [6.55 ± 2.035] 0.68 4.47
AST(U/L) [77.33 ± 68.82] 18 207
ALT(U/L) [109.25 ± 104.47] 20 343
